{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T01:39:41Z","timestamp":1775957981570,"version":"3.50.1"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T00:00:00Z","timestamp":1614816000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NIH T32 AI 052073-11\u00a0A1"],"award-info":[{"award-number":["NIH T32 AI 052073-11\u00a0A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 AI 007502-22"],"award-info":[{"award-number":["T32 AI 007502-22"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>A pharmacist-driven methicillin-resistant Staphylococcus aureus (MRSA) nasal polymerase chain reaction (PCR)-based testing protocol with a 70% acceptance rate for vancomycin discontinuation within 24 hours of negative results significantly reduced unnecessary vancomycin use with an estimated cost avoidance of $40 per vancomycin course. We found high concordance (141 of 147, 96%) of culture-based versus PCR-based MRSA nasal screening.<\/jats:p>","DOI":"10.1093\/ofid\/ofab099","type":"journal-article","created":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T20:59:24Z","timestamp":1615237164000},"source":"Crossref","is-referenced-by-count":20,"title":["Discontinuation Patterns and Cost Avoidance of a Pharmacist-Driven Methicillin-Resistant <i>Staphylococcus aureus<\/i> Nasal Polymerase Chain Reaction Testing Protocol for De-escalation of Empiric Vancomycin for Suspected Pneumonia"],"prefix":"10.1093","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6874-7798","authenticated-orcid":false,"given":"L","family":"Meng","sequence":"first","affiliation":[{"name":"Department of Quality, Patient Safety and Effectiveness, Stanford Health Care, Stanford, California, USA"},{"name":"Stanford Antimicrobial Safety and Sustainability Program, Stanford, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Pourali","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Stanford Health Care, Stanford, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M M","family":"Hitchcock","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, Virginia Commonwealth University Medical Center, Richmond, Virginia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D R","family":"Ha","sequence":"additional","affiliation":[{"name":"Department of Quality, Patient Safety and Effectiveness, Stanford Health Care, Stanford, California, USA"},{"name":"Stanford Antimicrobial Safety and Sustainability Program, Stanford, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Mui","sequence":"additional","affiliation":[{"name":"Department of Quality, Patient Safety and Effectiveness, Stanford Health Care, Stanford, California, USA"},{"name":"Stanford Antimicrobial Safety and Sustainability Program, Stanford, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W","family":"Alegria","sequence":"additional","affiliation":[{"name":"Department of Quality, Patient Safety and Effectiveness, Stanford Health Care, Stanford, California, USA"},{"name":"Stanford Antimicrobial Safety and Sustainability Program, Stanford, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Fox","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Stanford Health Care, Stanford, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Diep","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Stanford Health Care, Stanford, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Swayngim","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Stanford Health Care, Stanford, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Quality, Patient Safety and Effectiveness, Stanford Health Care, Stanford, California, USA"},{"name":"Stanford Antimicrobial Safety and Sustainability Program, Stanford, California, USA"},{"name":"Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Banaei","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA"},{"name":"Department of Pathology, Stanford University School of Medicine, Stanford, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Deresinski","sequence":"additional","affiliation":[{"name":"Department of Quality, Patient Safety and Effectiveness, Stanford Health Care, Stanford, California, USA"},{"name":"Stanford Antimicrobial Safety and Sustainability Program, Stanford, California, USA"},{"name":"Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7585-1809","authenticated-orcid":false,"given":"M","family":"Holubar","sequence":"additional","affiliation":[{"name":"Department of Quality, Patient Safety and Effectiveness, Stanford Health Care, Stanford, California, USA"},{"name":"Stanford Antimicrobial Safety and Sustainability Program, Stanford, California, USA"},{"name":"Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,3,4]]},"reference":[{"key":"2021081104203457800_CIT0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cid\/ciy024","article-title":"The","volume":"67","author":"Parente","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2021081104203457800_CIT0002","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.2146\/ajhp160964","article-title":"Impact of a pharmacist-driven methicillin-resistant Staphylococcus aureus surveillance protocol","volume":"74","author":"Willis","year":"2017","journal-title":"Am J Health Syst Pharm"},{"key":"2021081104203457800_CIT0003","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jcrc.2016.11.008","article-title":"Clinical utility of methicillin-resistant Staphylococcus aureus nasal polymerase chain reaction assay in critically ill patients with nosocomial pneumonia","volume":"38","author":"Smith","year":"2017","journal-title":"J Crit Care"},{"key":"2021081104203457800_CIT0004","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1128\/AAC.01965-12","article-title":"A trial of discontinuation of empiric vancomycin therapy in patients with suspected methicillin-resistant Staphylococcus aureus health care-associated pneumonia","volume":"57","author":"Boyce","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2021081104203457800_CIT0005","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s11096-018-0647-3","article-title":"Evaluation of a pharmacy-driven methicillin-resistant Staphylococcus aureus surveillance protocol in pneumonia","volume":"40","author":"Dunaway","year":"2018","journal-title":"Int J Clin Pharm"},{"key":"2021081104203457800_CIT0006","doi-asserted-by":"crossref","first-page":"e02432","DOI":"10.1128\/AAC.02432-16","article-title":"Nasal methicillin-resistant Staphylococcus aureus (MRSA) PCR","volume":"61","author":"Baby","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2021081104203457800_CIT0007","article-title":"Stanford Clinical Microbiology\u2013Antibiogram","author":"Niaz","year":"2018"},{"key":"2021081104203457800_CIT0008"},{"key":"2021081104203457800_CIT0009","doi-asserted-by":"crossref","first-page":"13","DOI":"10.29074\/ascls.27.1.13","article-title":"Cost-benefit and effectiveness analysis of rapid testing for MRSA carriage in a hospital setting","volume":"27","author":"Henson","year":"2014","journal-title":"Clin Lab Sci"},{"key":"2021081104203457800_CIT0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2020.11.008","article-title":"Cost\u2013benefit analysis comparing trough, two-level AUC and Bayesian AUC dosing for vancomycin","author":"Lee","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"2021081104203457800_CIT0011","author":"U.S. Department of Labor."},{"key":"2021081104203457800_CIT0012","author":"U.S. Department of Labor."},{"key":"2021081104203457800_CIT0013","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1469-0691.2010.03202.x","article-title":"Diagnostic accuracy of culture-based and PCR-based detection tests for methicillin-resistant Staphylococcus aureus: a meta-analysis","volume":"17","author":"Luteijn","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"2021081104203457800_CIT0014","doi-asserted-by":"crossref","first-page":"998.e1","DOI":"10.1016\/j.cmi.2015.07.006","article-title":"Nasal carriers are more likely to acquire exogenous Staphylococcus aureus strains than non-carriers","volume":"21","author":"Ghasemzadeh-Moghaddam","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"2021081104203457800_CIT0015","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/cid\/ciz974","article-title":"Determining the utility of methicillin-resistant Staphylococcus aureus nares screening in antimicrobial stewardship","volume":"71","author":"Mergenhagen","year":"2020","journal-title":"Clin Infect Dis"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofab099\/36451849\/ofab099.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/8\/4\/ofab099\/39630289\/ofab099.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/8\/4\/ofab099\/39630289\/ofab099.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T04:56:19Z","timestamp":1628657779000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofab099\/6158190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,4]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofab099","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,4,1]]},"published":{"date-parts":[[2021,3,4]]},"article-number":"ofab099"}}